15:50 | 02.11.2017
Smithers Avanza Invests to Support Growing Client Needs
Avanza, a boutique contract research organization (CRO) supporting
the pharmaceutical, agrochemical and chemical industries, continues to
invest in the space, equipment and personnel needed to address the
growing demand by clients for independent third-party, bioanalytical and
toxicology testing as part of their development of new pharmaceuticals,
biologics, biosimilars, chemicals and vaccines.
Over the past 12 months, Smithers Avanza has doubled the size of its now
15,000 square-foot Bioanalytical
Services laboratory, expanding its capability to perform
large-molecule analysis for clients developing new biologics.
Complementing the expansion of the physical space are several new
precision instruments and the introduction of 28 new employees.
Smithers Avanza’s Toxicology
Services business has also added new instrumentation and equipment
along with eight additional team members in recent months. These
investments position Smithers Avanza to meet industry demand for third
party DART (Developmental and Reproductive Toxicology) studies as well
as general toxicology and vaccine testing. All of this is part of the
organization’s strategy to provide a nimble and capable boutique CRO
option for clients.
“Our commitment to growing along with the needs of our clients shows in
the many investments we’ve made in our people and facilities over the
last year,” said Michael Hochschwender, President, Smithers Avanza and
CEO of The Smithers Group. “Clients appreciate our high scientific and
ethical standards along with our dedication to providing accurate data
on time, every time. In return for their faith in Smithers Avanza as a
partner, we will continue to augment and enhance our capabilities so
that we can provide the highest possible level of service.”
For more information about the Smithers Avanza portfolio of services,
About Smithers Avanza
Smithers Avanza is a contract research organization (CRO) supporting the
pharmaceutical, agrochemical and chemical industries. Our scientists
have expertise in the toxicologic assessment of pharmaceuticals,
agrochemicals and chemicals, large molecule bioanalysis, assay
development, validation and sample analysis at our GLP- and
GCP-compliant and CLIA-certified registered laboratory. Key Toxicology
Services expertise includes developmental and reproductive toxicology
(DART), general toxicology, and vaccine safety.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171102006057/en/